WVP
ONCS

Worth Venture Partners’s OncoSec Medical Incorporated ONCS Stock Holding History

Worth Venture Partners’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,784
Closed -$99K – 127
2019
Q2 		$99K Buy
+1,784
New +$172K 0.05% 76

Other funds holding ONCS

6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Worth Venture Partners's ONCS Position: Q3 2019 in Review

Worth Venture Partners sold out of OncoSec Medical Incorporated (ONCS) in Q3 2019, closing a stake of 1,784 shares — an estimated $99K sold.

Worth Venture Partners first reported a position in ONCS in Q2 2019 and held it in 1 quarter. The position peaked at $99K in Q2 2019. 22 funds tracked by Wall St. Rank hold ONCS as of Q3 2019.

  • Worth Venture Partners reported no remaining OncoSec Medical Incorporated position as of Q3 2019 after selling out during the quarter.
  • Worth Venture Partners sold 1,784 OncoSec Medical Incorporated shares in Q3 2019, an estimated $99K.
  • Worth Venture Partners first reported a position in OncoSec Medical Incorporated in Q2 2019 and held it in 1 quarter.
  • Worth Venture Partners's OncoSec Medical Incorporated position peaked at $99K in Q2 2019.
  • 22 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q3 2019.

Based on Worth Venture Partners's 13F filing for Q3 2019, filed 12 Nov 2019.